Clinical Trial Update: Linagliptin Response to OGTT in Prediabetes and Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating linagliptin response to oral glucose tolerance tests in people with prediabetes and type 2 diabetes completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes
• Type 2 Diabetes Mellitus

Drugs mentioned

• Linagliptin (linagliptin)

Snippet

Sponsor: National University of Malaysia | Conditions: PreDiabetes, Type 2 Diabetes | Phase 3 | Status: COMPLETED